Manufacturers Life Insurance Company, The Synthetic Biologics, Inc. Transaction History

Manufacturers Life Insurance Company, The

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$2.3 - $4.3 $24,373 - $45,567	-10,597 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$2.7 - $4.5 $35,046 - $58,410	-12,980 Reduced 55.05%	10,597 $3,000
Q2 2021 Aug 12, 2021	BUY	$4.6 - $7.2 $108,454 - $169,754	23,577 New	23,577 $14,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.